The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.

Editorial

Wednesday, 17 February 2016
Dr David Haslam, chair of the UK’s National Obesity Forum, provides a useful review of SGLT-2 inhibitors and their ability to lower glucose level, body weight and blood pressure in people with type 2 diabetes.
Category: Editorial
Topics covered:
Wednesday, 17 February 2016
Recent guidelines recommend two key steps to reduce ischaemic stroke in people with atrial fibrillation: 1. Improving the assessment of stroke risk and 2. Increasing the use of evidence-based anticoagulant therapy. In this article, leading specialists explain how to apply current guidelines to improve current practice in stroke prevention.
Category: Editorial
Wednesday, 17 February 2016
Cardiovascular disease (CVD) remains a national priority and primary care has a pivotal role in successfully addressing this urgent issue. This was the key message of Issues & Answers in Cardiovascular Disease 2015 conference, which participants and faculty said was the 'most successful' in the series to date.
Category: Editorial
Thursday, 28 January 2016
The BSH’s 18th annual meeting included a number of exciting presentations from some of the leading experts in heart failure. The report includes an update on some of the key trials that reported during the year.
Category: Editorial
Topics covered:
Tuesday, 15 December 2015
Recent advances in next generation sequencing (NGS) have reduced costs and made genetic diagnosis of familial hypercholesterolaemia (FH) quicker.  This article reviews some of the technological breakthroughs in DNA testing in FH and benefits to patients and clinicians. HEART UK - The Cholesterol Charity - has provided editorial support and review of this sponsored FH series.This article was made possible by an unrestricted educational grant by Sanofi, who had no control over content.
Category: Editorial
Saturday, 28 November 2015
Electronic cigarettes, e-cigs, vaporisers and the various other names given to these new devices have become a phenomenon. Their popularity over the past few years has grown significantly, with an expansion of highstreet e-cigarette shops, marketing via the internet and social media, as well as traditional approaches using print advertisement and mass media campaigns. Despite their increasing usage largely by smokers and ex-smokers, e-cigarettes have divided opinion as to whether they can offer real benefits or they are potentially damaging to public health. While a recent Public Health England review concluded that e-cigarettes could be prescribed to help smokers to quit, the Welsh government plans to restrict their use in the same way as for conventional cigarettes. This paper will present some of the main issues that surround e-cigarettes and highlight the potential consequences good and bad that this new technology may bring.
Category: Editorial
Topics covered:
Saturday, 28 November 2015
This article provides an overview of gout, including its optimal treatment, links with cardiovascular disease and the value of European and UK guidelines.
Category: Editorial
Topics covered:
Wednesday, 25 November 2015
Therapeutic interventions in atrial fibrillation primarily aim at reducing symptoms and improving or maintaining patients’ health-related quality of life (HRQoL). As most studies in this area have focused on randomised trial populations with highly symptomatic patients, this large observational study aims to assess HRQoL in a typical UK general practice setting.
Category: Editorial

Article search and filter